AI assistant
Sending…
Xspray Pharma — Major Shareholding Notification 2022
Apr 25, 2022
3129_iss_2022-04-25_82063192-17b9-41c9-b1ce-1523b5f128a5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer XSpray Pharma AB (publ)
Holder
Swedbank Robur Fonder AB
Instrument
| Instrument | Aktier SE0009973563 |
|---|---|
| Before the transaction | |
| Shares | 1,101,502 |
| Voting rights | 1,101,502 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 20/04/2022 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 901,502 |
| Directly held voting rights | 901,502 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.36 % |
| Directly held voting rights | 4.36 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| 4.36 % | 901,502 | |
| 4.36 % | 901,502 | |
| Name Mia Metso Ekberg Phone 08-58597525 Email [email protected] |
||
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Xspray Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Major Shareholding Notification
2026
May 4
Share Issue/Capital Change
2026
Apr 30
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 28
Interim / Quarterly Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Share Issue/Capital Change
2026
Mar 31